NASEM examines treatment for chronic illness following Lyme disease
By Christine Kilgore, Medscape
Advancing treatment for what has been variably called chronic Lyme and posttreatment Lyme disease (PTLD) is under the eyes of a National Academies of Science, Engineering, and Medicine (NASEM) committee of experts for the first time — a year after the NASEM shone a spotlight on the need to accelerate research on chronic illnesses that follow known or suspected infections.
The committee will not make recommendations on specific approaches to diagnosis and treatment when it issues a report in early 2025 but will instead present “consensus findings” on treatment for chronic illness associated with Lyme disease, including recommendations for advancing treatment. READ MORE
Dorothy Leland
Dorothy Leland is a longtime advocate and researcher focused on Lyme disease education, policy awareness, and patient support. She has contributed to numerous publications and works closely with medical professionals and organizations to improve understanding and treatment of tick-borne diseases.
Do You Have Lyme Disease?
Use our symptom checklist to better understand possible Lyme disease signs and next steps.
Newsletter Sign-up
Helpful Resources
Support LymeDisease.org
Your support helps us advocate for patients and fund critical Lyme disease research.
